Accuray is a global leader in the development and manufacturing of advanced radiation therapy systems, designed to deliver precise, effective, and patient-focused cancer treatments. Founded in 1990 by neurosurgeon Dr. John R. Adler, the company revolutionized the field of radiation oncology with the introduction of the CyberKnife® System—an innovative, robotic radiosurgery device capable of targeting tumors with sub-millimeter accuracy. Over the years, Accuray expanded its portfolio to include the TomoTherapy® and Radixact® Systems, providing versatile solutions for both stereotactic and conventional treatments.

Headquartered in Madison, Wisconsin, Accuray operates manufacturing facilities in the United States and China, and maintains a strong presence through regional offices across Europe and Asia. Its products are trusted by leading hospitals and cancer centers worldwide, enabling clinicians to treat a wide range of cancers while minimizing damage to surrounding healthy tissue.

Accuray’s mission is to broaden the curative potential of radiation therapy by combining clinical innovation with cutting-edge technology. Committed to improving patient outcomes, the brand invests heavily in research, training, and customer support to ensure the highest standard of care. With a focus on precision, accessibility, and compassion, Accuray continues to shape the future of cancer treatment.